Cardiovascular Registry of Atrial Fibrillation in Latin America: The LACROSS Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,016
- 试验地点
- 17
- 主要终点
- Percentage of electrical cardioversion
研究概览
简要总结
Follow a representative sample of Latin American patients diagnosed with atrial fibrillation to set data on demographic characteristics, documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death
详细描述
Patients will be followed 6 months and 1 year after the baseline visit and will be collected data of antithrombotic therapy, laboratory data, discontinuation rates of antithrombotic therapy and clinical outcomes.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age > 18 years-old that signed informed consent;
- •Atrial Fibrillation or Atrial Flutter at the time of inclusion documented in source document;
- •If the patient is not in atrial fibrillation or Atrial Flutter rhythm, s/he should have 2 electrographic records, at least 15 days apart between them, with one of them being performed within the last 6 months before enrollment (AF may be documented by 12-lead ECG, Holter monitor-24h);
排除标准
- •Patients who did not agree to participate.
- •Patients without possibility of monitoring for one year.
结局指标
主要结局
Percentage of electrical cardioversion
时间窗: 12 months
INR control rate
时间窗: 12 months
Oral anticoagulation discontinuation rate
时间窗: 12 months
Percentage of systemic embolism
时间窗: 12 months
Percentage of other cardiovascular hospitalization
时间窗: 12 months
Percentage of major bleeding
时间窗: 12 months
Percentage of atrioventricular junction ablation
时间窗: 12 months
Percentage of patients that need of pacemaker implantation
时间窗: 12 monts
Percentage of death
时间窗: 12 months
Percentage of stroke
时间窗: 12 months
Percentage of myocardial infarction
时间窗: 12 months
Percentage of percutaneous ablation of AF
时间窗: 12 months
次要结局
未报告次要终点